As of the latest Form 4 filed Jun 22, 2026.
What Gyre Therapeutics Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 38 most recent filings for GYRE.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-18 | Ye Weiguo Chief Operating Officer | SSale | −3.00K | $6.35 | $19.1K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Ye Weiguo, Chief Operating Officer | MExercise | +3.00K | $0.75 | $2.25K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-10 | Ye Weiguo, Chief Operating Officer | SSale | −5.00K | $6.24 | $31.2K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-10 | Ye Weiguo, Chief Operating Officer | MExercise | +5.00K | $0.75 | $3.75K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-09 | Ye Weiguo, Chief Operating Officer | SSale | −3.00K | $6.15 | $18.4K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-09 | Ye Weiguo, Chief Operating Officer | MExercise | +3.00K | $0.75 | $2.25K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Ye Weiguo Chief Operating Officer | SSale | −2.80K | $6.17 | $17.3K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Ye Weiguo, Chief Operating Officer | MExercise | +2.80K | $0.75 | $2.10K | No | Form 4 ↗ |
| 2026-06-11 | 2026-06-10 | Ye Weiguo Chief Operating Officer | SSale | −6.42K | $6.21 | $39.9K | No | Form 4 ↗ |
| 2026-06-11 | 2026-06-10 | Ye Weiguo, Chief Operating Officer | MExercise | +6.42K | $0.75 | $4.81K | No | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Ye Weiguo, Chief Operating Officer | SSale | −14.5K | $6.14 | $89.0K | No | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Ye Weiguo, Chief Operating Officer | MExercise | +14.5K | $0.75 | $10.9K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Ye Weiguo Chief Operating Officer | SSale | −15.4K | $6.40 | $98.6K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Ye Weiguo, Chief Operating Officer | MExercise | +15.4K | $0.75 | $11.6K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Ye Weiguo, Chief Operating Officer | SSale | −19.6K | $6.13 | $120K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Ye Weiguo, Chief Operating Officer | MExercise | +19.6K | $0.75 | $14.7K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | Ye Weiguo Chief Operating Officer | SSale | −4.00K | $6.10 | $24.4K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | Ye Weiguo, Chief Operating Officer | MExercise | +4.00K | $0.75 | $3.00K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Ye Weiguo, Chief Operating Officer | SSale | −3.50K | $6.08 | $21.3K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Ye Weiguo, Chief Operating Officer | MExercise | +3.50K | $0.75 | $2.63K | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-21 | Ye Weiguo Chief Operating Officer | SSale | −12.8K | $6.15 | $78.8K | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-21 | Ye Weiguo, Chief Operating Officer | MExercise | +12.8K | $0.75 | $9.62K | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Ye Weiguo, Chief Operating Officer | SSale | −9.40K | $6.15 | $57.8K | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Ye Weiguo, Chief Operating Officer | MExercise | +9.40K | $0.75 | $7.05K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Ye Weiguo Chief Operating Officer | SSale | −9.12K | $6.37 | $58.1K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Ye Weiguo, Chief Operating Officer | MExercise | +9.12K | $0.75 | $6.84K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Ye Weiguo, Chief Operating Officer | SSale | −200.00 | $6.62 | $1.32K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Ye Weiguo, Chief Operating Officer | MExercise | +200.00 | $0.75 | $150.00 | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Ye Weiguo Chief Operating Officer | SSale | −13.1K | $6.65 | $87.1K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Ye Weiguo, Chief Operating Officer | MExercise | +13.1K | $0.75 | $9.82K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-14 | Ye Weiguo, Chief Operating Officer | SSale | −15.6K | $6.91 | $108K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-14 | Ye Weiguo, Chief Operating Officer | MExercise | +15.6K | $0.75 | $11.7K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | Luo Ying Chief Executive Officer | SSale | −10.1K | $8.04 | $81.5K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Luo Ying, Chief Executive Officer | SSale | −179.00 | $8.01 | $1.43K | Yes (planned) | Form 4 ↗ |
| 2024-05-02 | 2024-05-01 | USMAN NASSIM Director | SSale | −100.00 | $15.63 | $1.56K | Yes (planned) | Form 4 ↗ |
| 2024-05-02 | 2024-05-01 | USMAN NASSIM, Director | SSale | −5.00K | $14.90 | $74.5K | Yes (planned) | Form 4 ↗ |
| 2024-05-02 | 2024-05-01 | USMAN NASSIM, Director | SSale | −14.9K | $13.86 | $207K | Yes (planned) | Form 4 ↗ |
| 2024-05-02 | 2024-05-01 | USMAN NASSIM, Director | MExercise | +20.0K | $6.93 | $139K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also GYRE’s full analysis or the market-wide insider trading feed. The tabs above jump to GYRE’s other SEC data.
Source: SEC Form 4 filings for GYRE, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.